» Articles » PMID: 16150122

Expression of Allograft Inflammatory Factor-1 and Haeme Oxygenase-1 in Brains of Rats Infected with the Neurotropic Borna Disease Virus

Overview
Specialty Neurology
Date 2005 Sep 10
PMID 16150122
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Experimental infection of Lewis rats with Borna disease virus (BDV) causes an immune-mediated nonpurulent meningoencephalitis. Viral persistence in the central nervous system is accompanied by mononuclear infiltrates, activated monocytic/microglial cells and reactive astrocytes. The immune-mediated process was further characterized by expression analysis of allograft inflammatory factor-1 (AIF-1), a novel marker of monocyte/microglial activation and of glial fibrillary acid protein (GFAP) between day 3 and day 50 post infection (p.i.). Potential neuroprotective effects of these cells were studied by the induction of haeme oxygenase-1 (HO-1), a defensive molecule against oxidative stress in various brain insults. In BDV-infected rat brains, mononuclear infiltrates and AIF-1 expression increased up to day 28 p.i. During early time points p.i., AIF-1 expression was mainly found in inflammatory lesions and adjacent brain parenchyma. Already 24 days p.i., a widespread upregulation of AIF-1 was observed which declined only moderately beyond day 28 p.i. HO-1 induction was maximal between days 18 and 28 p.i. Increased amounts of GFAP-positive astrocytes were present beyond 24 days p.i. Viral antigen expression increased simultaneously to the inflammatory reaction and persisted up to 50 days p.i. Widespread upregulation of AIF-1 indicates an early, long-lasting microglial activation, which might be involved in the immunesurveillance of the immune-mediated inflammatory events. The early peak of HO-1 most likely represents a neuroprotective, anti-inflammatory response by invading monocytes, microglial cells and astrocytes during the formation of encephalitic lesions and acute viral replication.

Citing Articles

Comparative study of virus and lymphocyte distribution with clinical data suggests early high dose immunosuppression as potential key factor for the therapy of patients with BoDV-1 infection.

Vollmuth Y, Jungback N, Mogele T, Schmidt-Graf F, Wunderlich S, Schimmel M Emerg Microbes Infect. 2024; 13(1):2350168.

PMID: 38687703 PMC: 11107860. DOI: 10.1080/22221751.2024.2350168.


Long-term Elevation of Complement Factors in Cerebrospinal Fluid of Patients With Borna Disease Virus 1 Encephalitis.

Bauswein M, Zoubaa S, Toelge M, Eidenschink L, Riemenschneider M, Neumann B J Infect Dis. 2024; 230(4):e943-e953.

PMID: 38591239 PMC: 11481329. DOI: 10.1093/infdis/jiae183.


AIF1: Function and Connection with Inflammatory Diseases.

De Leon-Oliva D, Garcia-Montero C, Fraile-Martinez O, Boaru D, Garcia-Puente L, Rios-Parra A Biology (Basel). 2023; 12(5).

PMID: 37237507 PMC: 10215110. DOI: 10.3390/biology12050694.


AIF1 was identified as an up-regulated gene contributing to CSFV Shimen infection in porcine alveolar macrophage 3D4/21 cells.

Gong X, Li X, You X, Hu A, Liu M, Yao H PeerJ. 2020; 8:e8543.

PMID: 32110485 PMC: 7032059. DOI: 10.7717/peerj.8543.


The neuropathology of fatal encephalomyelitis in human Borna virus infection.

Liesche F, Ruf V, Zoubaa S, Kaletka G, Rosati M, Rubbenstroth D Acta Neuropathol. 2019; 138(4):653-665.

PMID: 31346692 PMC: 6778062. DOI: 10.1007/s00401-019-02047-3.